Adler-Moore, J., Lewis, R. E., Brüggemann, R. J. M., Rijnders, B. J. A., Groll, A. H., & Walsh, T. J. (2019). Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Clin Infect Dis.
Citación estilo ChicagoAdler-Moore, Jill, Russell E. Lewis, Roger J M. Brüggemann, Bart J A. Rijnders, Andreas H. Groll, y Thomas J. Walsh. "Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B." Clin Infect Dis 2019.
Cita MLAAdler-Moore, Jill, et al. "Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B." Clin Infect Dis 2019.
Precaución: Estas citas no son 100% exactas.